The page lists 25 projects related to the topic "lymphoma".
# | |||
---|---|---|---|
1 | DNAendProtection | DNA end protection in Immunity and Cancer | 2015 |
2 | LYMPHOSIGN | Integrated study of the role of B-cell receptor signaling in the development of Follicular Lymphoma | 2015 |
3 | TITLY | Inhibition of the T-cell receptor signalling pathway for treatment of T-cell lymphoma | 2015 |
4 | HYscreen | A fast, cost-effective breath analysis technology for Helicobacter pYlori screening at both large and small scale. | 2015 |
5 | ALKATRAS | ALK Activation as a target of TRAanslational Science (ALKATRAS): Break free from cancer | 2015 |
6 | HEAL-BY-MIRNA | microRNA replacement therapy for mature B cell neoplasias | 2016 |
7 | BCM-UPS | Dissecting the role of the ubiquitin proteasome system in the pathogenesis and therapy of B-cell malignancies | 2016 |
8 | chemos | Chemical Hematology: breaking resistance of hematological malignancies through personalized drug trials | 2016 |
9 | VIVAVE | Viral Vaccine Vectors in Personalized Medicine | 2017 |
10 | EwiSarc | A novel in vivo platform to study and target undruggable Ewing onco-chimera. | 2017 |
11 | BCRdangerCOMPETITION | The role of danger signal and cellular competition in the elimination of B cells lacking the B cell receptor. | 2017 |
12 | Secret Surface | The cell surface tetraspanin web drives tumour development and alters metabolic signalling | 2017 |
13 | LUPUSCARE | PRECISION CARE IN SYSTEMIC AUTOIMMUNITY: AN INTEGRATED MULTI-TISSUE/LEVEL APPROACH FOR SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) | 2017 |
14 | Proteasome in cancer | Identification of the proteasome machinery targets in human cancer | 2018 |
15 | IGpath | Dissecting the functional pathways of B cell receptor immunoglobulin in antigen driven mature B cell lymphomas | 2018 |
16 | PORTAL | Personalized oncology for refractory and relapsed lymphoma using humanized patient derived othotopic xenografts (ImmunePDOX) | 2018 |
17 | CARAMBA | SLAMF7-CAR T cells prepared by Sleeping Beauty gene-transfer for immunotherapy of multiple myeloma – a rare hematologic disease | 2018 |
18 | SYST-iMYC | Development of an effective and safe systemic Myc inhibitor for the treatment of multiple cancer types. | 2018 |
19 | 20SInhibitor | Selective 20S proteasome inhibition for multiple myeloma therapy | 2019 |
20 | PI3K MODULATORS | Identification and characterisation of new class of PI3K modulators in oncology | 2019 |
21 | Exh-Res-CART | Exhaustion-resistant CAR-T cells for the treatment of solid tumours | 2019 |
22 | ONCO-BOOST | Boosting immuno-oncology strategies with innovative immuno-stimulants derived from bacteria, to be administrated in combination with therapeutic monoclonal antibodies | 2019 |
23 | T-NHL SUPRESSORS | Tumor suppressor pathways counteracting oncogenic immune receptor signaling in T-Cell Lymphoma | 2019 |
24 | IL7RsignaTHER | Antibody-based IL-7R targeted therapies | 2020 |
25 | PRECISMEDLYM | Aggressive T cell Lymphomas, integrated clinical and genomic analysis for a precision medicine. | 2020 |